Biologic efficacy in the treatment of cutaneous immune-related adverse events: A single center retrospective cohort study

被引：0
|
作者：
Ebriani, J. [1 ]
Westmeijer, M. [1 ]
Holt, A. [1 ]
Brumbaugh, B. [1 ]
Ma, K. [1 ]
Chen, S. T. [1 ]
机构：
[1] Massachusetts Gen Hosp, Dermatol, Boston, MA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2024年 / 144卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
LB921
引用
收藏
页码：S161 / S161
页数：1
相关论文
共 50 条
  • [31] Cutaneous Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors and Their Management
    Pach, J.
    Leventhal, J. S.
    CRITICAL REVIEWS IN IMMUNOLOGY, 2022, 42 (04) : 1 - 20
  • [32] Cutaneous immune-related adverse events to immune checkpoint inhibitors: A dermatology perspective
    Muntyanu, Anastasiya
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB42 - AB42
  • [33] Treating Cutaneous Immune-Related Adverse Events from Immune Checkpoint Blockade
    Adusumilli, Nagasai C.
    Friedman, Adam J.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2021, 20 (10) : 1133 - 1134
  • [34] Management of immune-related adverse events: A single-center retrospective analysis in a real-world scenario.
    Iacono, Donatella
    Vitale, Maria Grazia
    Cortiula, Francesco
    Macerelli, Marianna
    Cinausero, Marika
    Minisini, Alessandro Marco
    Valent, Francesca
    Tullio, Annarita
    Palmero, Lorenza
    Targato, Giada
    Zara, Diego
    Fasola, Gianpiero
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] A Single Center Retrospective Study of the Impact of COVID-19 Infection on Immune-related Adverse Events in Cancer Patients Receiving Immune Checkpoint Inhibitors
    Guo, Mengni
    Liu, Jieying
    Miao, Ruoyu
    Ahmed, Zohaib
    Yu, James
    Guan, Jian
    Ahmad, Sarfraz
    Zhou, Shuntai
    Grove, Angela
    Manoucheri, Manoucher
    Socinski, Mark A.
    Mekhail, Tarek
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (09) : 389 - 395
  • [36] Tofacitinib for the treatment of immune-related adverse events in cancer immunotherapy: a multi-center observational study
    Liu, Qing
    Liu, Mengling
    Zou, Zhiguo
    Lin, Jinyi
    Zhang, Ningping
    Zhao, Lin
    Zhou, Jiahua
    Zhou, Haojie
    Zhou, Xin
    Jiao, Xiaodong
    Yu, Yiyi
    Liu, Tianshu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [37] Musculoskeletal Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy: Single Center Experience
    Saygin, Didem
    Bastacky, Melissa
    Mascara, Gerard
    Brenner, Timothy L.
    Oddis, Chester
    Moghadam-Kia, Siamak
    Ascherman, Dana
    Davar, Diwakar
    Aggarwal, Rohit
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [38] Neurological immune-related adverse events treated with immune check point inhibitors: A single center experience
    Kamada, S.
    Hanazono, A.
    Sanpei, Y.
    Sugawara, M.
    Iijima, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [39] Cutaneous immune-related adverse events are undertreated in advanced cancer patients
    Chang, M.
    Otto, T.
    Jacoby, T.
    Thompson, L.
    Reynolds, K.
    Chen, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (09) : B10 - B10
  • [40] Tissue-specific homing in cutaneous immune-related adverse events
    Leung, B.
    Zhang, S.
    Nguyen, N.
    Wan, G.
    Jairath, R.
    Alexander, N.
    Phillipps, J.
    Zubiri, L.
    Demehri, S.
    Yu, K.
    Gusev, A.
    Kwatra, S. G.
    LeBoeuf, N.
    Reynolds, K.
    Semenov, Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S44 - S44
12345